This Article Immediate free access via SAGE Open OA Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (10) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Elliott, A. M Articles by Whitwortha, J. A. Search for Related Content PubMed PubMed Citation Articles by Elliott, A. M Articles by Whitwortha, J. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Childhood Immunization High Risk Pregnancy Immunization Social Bookmarking                         What's this?

The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]

Uganda Virus Research Institute, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK

Moses Kizza

Uganda Virus Research Institute, Entebbe, Uganda

Maria A Quigley

London School of Hygiene & Tropical Medicine, London, UK; National Perinatal Epidemiology Unit, Oxford University, Headington, Oxford, UK

Juliet Ndibazza

Margaret Nampijja

Lawrence Muhangi

Uganda Virus Research Institute, Entebbe, Uganda

Linda Morison

London School of Hygiene & Tropical Medicine, London, UK

Proscovia B Namujju

Uganda Virus Research Institute, Entebbe, Uganda

Moses Muwanga

Entebbe Hospital, Entebbe, Uganda

Narcis Kabatereine

Vector Control Division, Ministry of Health, Kampala, Uganda

James AG Whitwortha

Uganda Virus Research Institute, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, London, UK

Background Helminths have profound effects on the immune response, allowing long-term survival of parasites with minimal damage to the host. Some of these effects "spill-over", altering responses to non-helminth antigens or allergens. It is suggested that this may lead to impaired responses to immunizations and infections, while conferring benefits against inflammatory responses in allergic and autoimmune disease. These effects might develop in utero, through exposure to maternal helminth infections, or through direct exposure in later life.

Purpose To determine the effects of helminths and their treatment in pregnancy and in young children on immunological and disease outcomes in childhood.

Methods The trial has three randomized, double-blind, placebo-controlled interventions at two times, in two people: a pregnant woman and her child. Pregnant women are randomized to albendazole or placebo and praziquantel or placebo. At age 15 months their children are randomized to three-monthly albendazole or placebo, to continue to age five years. The proposed designation for this sequence of interventions is a 2 x 2(x2) factorial design. Children are immunized with BCG and against polio, Diphtheria, tetanus, Pertussis, Haemophilus, hepatitis B and measles. Primary immunological outcomes are responses to BCG antigens and tetanus toxoid in whole blood cytokine assays and antibody assays at one, three and five years of age. Primary disease outcomes are incidence of malaria, pneumonia, diarrhoea, tuberculosis, measles, vertical HIV transmission, and atopic disease episodes, measured at clinic visits and twice-monthly home visits. Effects on anaemia, growth and intellectual development are also assessed.

Conclusion This trial, with a novel design comprising related interventions in pregnant women and their offspring, is the first to examine effects of helminths and their treatment in pregnancy and early childhood on immunological, infectious disease and allergic disease outcomes. The results will enhance understanding of both detrimental and beneficial effects of helminth infection and inform policy.

References

• Disease Watch focus. Soil-transmitted helminthiasis. Nat Rev Microbiol 2004; 2: 818–819.
• Chitsulo L, Engels D, Montressor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000; 77: 41–51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Thinking beyond deworming. Lancet (editorial) 2004; 364: 1993–1994.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Allen HE, Crompton DWT, de Silva N, LoVerde PT, Olds GR. New policies for using anthelmintics in high risk groups. Trends Parasitol 2002; 18: 381–382.[CrossRef][Medline] [Order article via Infotrieve]
• Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3: 733–744.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Actor J, Shirai M, Kullberg M, Buller R, Sher A, Berzofsky J. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993; 90: 948–952.[Abstract/Free Full Text]
• Brady MT, O-Neill SM, Dalton JP, Mills KH. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun 1999; 67: 5372–5378.[Abstract/Free Full Text]
• Pearlman E, Kazura JW, Hazlett FE, Boom WH. Modulation of murine cytokine responses to myco bac-terial antigens by helminth-induced T helper 2 cell esponses. J Immunol 1993; 151: 4857–4864.[Abstract]
• Erb KJ, Trujillo C, Fugate M, Moll H. Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Mycobacterium tuberculosis form the lungs of mice. Clin Diagn Lab Immunol 2002; 9: 727–730.[CrossRef][Medline] [Order article via Infotrieve]
• Elias D, Akuffo H, Thors C, Pawlowski A, Britton S. Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol 2005; 139: 398–404.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kilian HD, Nielsen G. Cell mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients. Trop Med Parasitol 1989; 40: 285–291.[Web of Science][Medline] [Order article via Infotrieve]
• Kilian HD, Nielsen G. Cell mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop Med Parasitol 1989; 40: 445–453.[Web of Science][Medline] [Order article via Infotrieve]
• Sabin EA, Ilma Araujo M, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996; 173: 269–272.[Web of Science][Medline] [Order article via Infotrieve]
• Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis. J Infect Dis 1998; 178: 1133–1138.[Web of Science][Medline] [Order article via Infotrieve]
• Elias D, Wolday D, Akuffo H et al. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol 2001; 123: 219–225.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bentwich Z, Kalinkovich A, Weisman Z et al. Can eradication of helminth infections change the face of AIDS and tuberculosis? Immunol Today 1999; 11: 485–487.
• Bundy D, Sher A, Michael E. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Parasitol Today 2000; 16: 273–274.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Elias D, Akuffo H, Pawlowski A et al. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 2005, 23: 1326–1334.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Malhotra I, Mungai P, Wamachi A et al. Helminth- and Bacillus-Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162: 6843–6848.[Abstract/Free Full Text]
• Elliott AM, Namujju PB, Mawa PA et al. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guerin (BCG) immunisation [ISRCTN32849447] BMC Infect Dis 2005; 5: 115-115.[CrossRef][Medline] [Order article via Infotrieve]
• Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 2001; 22: 372–377.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cooke A, Tonks P, Jones FM et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999; 21: 169–176.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Elliott AM, Mpairwe H, Quigley MA et al. Helminth infection during pregnancy and development of infantile eczema. JAMA 2005; 294: 2032–2034.[Free Full Text]
• Falcone FH, Pritchard DI. Parasite role reversal: worms on trial. Trends Parasitol 2005: 21; 157–160.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128: 825–832.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nacher M. Interactions between worm infections and malaria. Clin Rev Allergy Immunol 2004; 26: 85–92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Brown M, Kizza M, Watera C et al. Helminth infection is not associated with faster HIV disease progression in co-infected adults in Uganda. J Infect Dis 2004; 190: 1869–1879.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mpairwe H, Muhangi L, Namujju PB et al. HIV risk perception and prevalence in a programme for prevention of mother-to-child HIV transmission: comparison of women who accept voluntary counselling and testing and those tested anonymously. J Acquir Immune Defic Syndr 2005; 39: 354–358.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Guay L, Musoke P, Fleming T et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354: 795–802.[Web of Science][Medline] [Order article via Infotrieve]
• Bundy DA, Hall A, Medley GF, Savioli L. Evaluating measures to control intestinal parasitic infections. World Health Stat Q 1992; 45: 168–179.[Medline] [Order article via Infotrieve]
• Bukusuba JW, Hughes P, Kizza M et al. Screening for intestinal helminth infection in a semi-urban cohort of pregnant women in Uganda. Trop Doc 2004; 34: 27–28.[Web of Science][Medline] [Order article via Infotrieve]
• Katz N, Chaves A, Pellegrino N. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14: 397–400.[Medline] [Order article via Infotrieve]
• Friend J. Helminths. In Collee JG, Fraser A, Marmion B, Simmons A eds. Mackie & McCartney Practical Medical Microbiology, Churchill Livingstone, 1996.
• Melrose WD, Turner PF, Pisters P, Turner B. An improved Knott's concentration test for the detection of microfilariae. Trans Roy Soc Trop Med Hyg 2000; 94: 176-176.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Elliott AM, Hurst TJ, Baleyku M et al. The immune response to Mycobacterium tuberculosis in HIV infected and uninfected adults: Application of the whole blood cytokine assay in an epidemiological study in Uganda. Int J Tuberc Lung Dis 1999; 3: 239–247.[Web of Science][Medline] [Order article via Infotrieve]
• Lotte A, Wasz-Höckert O, Poisson N et al. BCG complications. Adv Tuber Res 1984, 21: 107–193.
• Drakely CJ, Corran PH, Coleman PG et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 2005; 102: 5108–5113.[Abstract/Free Full Text]
• Soysal A, Millington KA, Bakir M et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective, community-based study. Lancet 2005; 366: 1443–1451.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Programme for the Control of Acute Respiratory Infections. Acute respiratory infections in children: case management in small hospitals in developing countries. World Health Organization/ARI/90.5.
• Cutts FT, Zaman SM, Enwere G et al. Efficacy of ninevalent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365: 1139–1146.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cousens SN, Feachem RG, Kirkwood B, Mertens TE, Smith PG. Case-control studies of childhood diarrhoea: I minimising bias. World Health Organization/CDD/ EDP/88.2.
• Smith T, Armstrong Schellenberg J, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 1994; 13: 2345–2358.[Web of Science][Medline] [Order article via Infotrieve]
• Morley D. Severe measles in Africa. In Paediatric priorities in the developing world, Butterworths, 1973.
• Khan EA, Starke JR. Diagnosis of tuberculosis in children: increased need for better methods. Emerging Infect Dis 1995; 1: 115–123.[Web of Science][Medline] [Order article via Infotrieve]
• Fourie PB, Becker PJ, Festenstein F et al. Procedures for developing a simple scoring method based on unsophisticated criteria for screening children for tuberculosis. Int J Tuberc Lung Dis 1998: 2; 116–123.[Web of Science][Medline] [Order article via Infotrieve]
• Asher MI, Keil U, Anderson HR et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483–491.[Abstract]
• van Rie A, Beyers N, Gie RP et al. Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child 1999; 80: 433–437.[Abstract/Free Full Text]
• Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Global burden of tuberculosis. Estimated incidence, prevalence and mortality by country. JAMA 1999; 282: 677–686.[Abstract/Free Full Text]
• Smith PG, Day NE. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol 1984; 13: 356–365.[Abstract/Free Full Text]
• Elliott AM, Mawa PA, Joseph S et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans Roy Soc Trop Med Hyg 2003; 97: 103–108.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Torlesse H, Hodges M. Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone). Trans Roy Soc Trop Med Hyg 2001; 95: 195–201.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kiambo Njagi J, Magnussen P, Estambale B, Ouma J, Mugo B. Prevention of anaemia in pregnancy using insecticide-treated bed nets and sulfadoxinepyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Trans Roy Soc Trop Med Hyg 2003; 97: 277–282.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Villar J, Klebanoff M, Kestler E. The effect on fetal growth of protozoan and helminthic infection during pregnancy. Obstet Gynecol 1989; 74: 915–920.[Web of Science][Medline] [Order article via Infotrieve]
• De Silva NR, Sirsena JLGJ, Gunasekera DPG, Ismail MM, de Silva HJ. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet 1999; 353: 1145–1149.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Christian P, Kahtry SK, West KP. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 2004; 364: 981–983.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bradley M, Horton J. Assessing the risk of benzimidazole therapy during pregnancy. Trans Roy Soc Trop Med Hyg 2001, 95: 72–73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Stolzfus RJ, Kvalsvig JD, Chwaya HM et al. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. Br Med J 2001; 323: 1–8.[Free Full Text]
• Stolzfus RJ, Chwaya HM, Montresor A et al. Low dose iron supplementation improves iron status and appetite but not anaemia, whereas quarterly anthelmintic treatment improves growth, appetite and anemia in Zanzibari preschool children. J Nutr 2004; 134: 348–356.[Abstract/Free Full Text]
• Olds GR, King C, Hewlett J et al. Double-blind placebocontrolled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J Infect Dis 1999; 179: 996–1003.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schistosomiasis Control Initiative. Available at http://www.schisto.org. Accessed 7 December 2005.
• Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339–1345.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yemaneberhan H, Bekele Z, Venn A et al. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997; 350: 85–90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Venn AJ, Yemaneberhan H, Bekele Z et al. Increased risk of allergy associated with the use of kerosene fuel in the home. Am J Resp Crit Care Med 2001; 164: 1660–1664.[Abstract/Free Full Text]
• Venn AJ, Yemaneberhan H, Lewis S, Parry E, Britton J. Proximity of the home to roads and the risk of wheeze in an Ethiopian population. Occup Environ Med 2005; 62: 376–380.[Abstract/Free Full Text]

Clinical Trials, Vol. 4, No. 1, 42-57 (2007)
DOI: 10.1177/1740774506075248


SAGE Open article

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Immediate free access via SAGE Open OA Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (10) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Elliott, A. M Articles by Whitwortha, J. A. Search for Related Content PubMed PubMed Citation Articles by Elliott, A. M Articles by Whitwortha, J. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Childhood Immunization High Risk Pregnancy Immunization Social Bookmarking                         What's this?